Beyond Cancer™ Selected to Present Proffered Posters

GARDEN CITY, N.Y. and HAMILTON, Bermuda, Oct. 04, 2023 -- Beyond Cancer, Ltd., an affiliate of Beyond Air, Inc. that is developing ultra-high concentration nitric oxide as an immunotherapeutic...

Related Keywords

Jerusalem , Israel General , Israel , Boston , Massachusetts , United States , Bermuda , American , Fred Dirbas , Matt Johnson , Sunil Panchal , Mark Pegram , Yana Epshtein , Corey Davis , International Conference On Molecular , Details Of The Company , Lifesci Advisors , Clinical Translational Research Unit , Intratumoral Administration Of Ultra High , Stanford University , National Cancer Institute , European Organisation For Research , American Association For Cancer Research , Nasdaq , Globenewswire Inc , Exchange Commission , National Institute Of Spine , Stanford University School Of Medicine , Dean For Clinical Research Quality , Cancer Ltd , Corporate Development Strategy , Hebrew University Of Jerusalem , International Conference , Molecular Targets , Cancer Therapeutics , Ultra High Concentration Nitric Oxide , High Tumor Regression Rates , Prolonged Survival , Poster Session , Exhibit Hall , Translational Science , Vitro Studies , Advisory Board , Surgical Oncology , University School , Yuan Huey Hung Professor , Medical Director , Associate Dean , Clinical Research Quality , Nitric Oxide , Autism Spectrum , Beyond Cancer , Beyond Air , Annual Report , Sci Advisors , Markets ,